In-depth articles on biological evaluation, EU MDR, FDA biocompatibility, and medical device regulatory strategy — written by a practising ISO 10993 consultant.
The 2025 revision of ISO 10993-1 is not just a terminology update. It fundamentally reframes how biological safety must be evaluated across the entire device lifecycle — and many existing BEPs have gaps that need addressing now.
Follow MedTechISO on LinkedIn for ISO 10993, EU MDR and FDA biocompatibility updates published every week.